Baguio, Gertrudes C.
HRN: 00-15-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
CEFTRIAXONE 1G (VIAL)
05/07/2023
05/14/2023
IV
2 Grams
OD
T/C Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes